Log In
Print
BCIQ
Print
Print this Print this
 

EZH2 inhibitors

  Manage Alerts
Collapse Summary General Information
Company Constellation Pharmaceuticals Inc.
DescriptionEnhancer of zeste homolog 2 (EZH2) inhibitor
Molecular Target Enhancer of zeste homolog 2 (EZH2)
Mechanism of ActionEnhancer of zeste homolog 2 (EZH2) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today